Clinical Trial Update: Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of thalidomide with or without fludarabine in patients with small lymphocytic lymphoma and chronic lymphocytic leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED